Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Accounts Payables (2017 - 2026)

Inspire Medical Systems' Accounts Payables history spans 10 years, with the latest figure at $41.8 million for Q1 2026.

  • On a quarterly basis, Accounts Payables rose 43.63% to $41.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $41.8 million, a 43.63% increase, with the full-year FY2025 number at $36.6 million, down 5.49% from a year prior.
  • Accounts Payables hit $41.8 million in Q1 2026 for Inspire Medical Systems, up from $36.6 million in the prior quarter.
  • Over the last five years, Accounts Payables for INSP hit a ceiling of $59.2 million in Q3 2025 and a floor of $16.0 million in Q2 2022.
  • Historically, Accounts Payables has averaged $35.7 million across 5 years, with a median of $36.6 million in 2025.
  • Biggest five-year swings in Accounts Payables: skyrocketed 149.24% in 2023 and later plummeted 33.48% in 2025.
  • Tracing INSP's Accounts Payables over 5 years: stood at $26.8 million in 2022, then skyrocketed by 44.67% to $38.8 million in 2023, then dropped by 0.39% to $38.7 million in 2024, then fell by 5.49% to $36.6 million in 2025, then increased by 14.45% to $41.8 million in 2026.
  • Business Quant data shows Accounts Payables for INSP at $41.8 million in Q1 2026, $36.6 million in Q4 2025, and $59.2 million in Q3 2025.